A Study of a Rilpivirine Extended-Release Suspension in Healthy Participants
Clinical trial NCT05112939 · COMPLETED
Trial details
- NCT number
- NCT05112939
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2024-05-23
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.